Welcome to Metabogen

A better public health

As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and next generation probiotics.

MetabogenTechnology

MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.

PharmaceuticalIndustry

By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development.

Next GenerationProbiotics

Thorough investigation of the microbiome and identification of bacterial strains provides the probiotic industry with new tools for more precise product development.

Platform

As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and next generation probiotics. The company was founded based on world leading science from the labs of Professor Fredrik Bäckhed and Professor Jens B Nielsen, to provide commercial access to metagenome research and development. MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.

Latest news

4th March 2019

Welcome Mattias!

From March 4, Mattias Bergentall joins the MetaboGen team as our new microbiologist. We welcome Mattias and look forward to continuing ou (...) Read the full story

19th December 2018

We are hiring!

MetaboGen is growing and we are now looking for a Microbiologist and a Project Manager to join our development team. Read more about the (...) Read the full story